MILWAUKEE


,


Nov. 29, 2022


/PRNewswire/ — Ademi LLP is investigating Apollo Endosurgery (Nasdaq: APEN) for possible breaches of fiduciary duty and other violations of law in its transaction with Boston Scientific.

Click here to learn how to join the action https://www.ademilaw.com/case/apollo-endosurgery-inc or call

Guri Ademi

toll-free at 866-264-3995.  There is no cost or obligation to you.

Ademi LLP alleges Apollo Endosurgery’s financial outlook and prospects are excellent and yet Apollo Endosurgery shareholders are expected to collectively own only

$10

per share. The transaction agreement unreasonably limits competing bids for Apollo Endosurgery by imposing a significant penalty if Apollo Endosurgery accepts a superior bid. Apollo Endosurgery insiders will receive substantial benefits as part of change of control arrangements.

We are investigating the conduct of Apollo Endosurgery’s board of directors, and whether they are (i) fulfilling their fiduciary duties to all shareholders, and (ii) obtaining a fair and reasonable price for Apollo Endosurgery.

If you own Apollo Endosurgery common stock and wish to obtain additional information, please contact

Guri Ademi

either at

[email protected]

or toll-free: 866-264-3995, or

https://www.ademilaw.com/case/apollo-endosurgery-inc

.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP


Guri Ademi


Toll Free: (866) 264-3995

Fax: (414) 482-8001

View original content to download multimedia:

https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-apollo-endosurgery-inc-has-obtained-a-fair-price-in-its-transaction-with-boston-scientific-301688882.html

SOURCE Ademi LLP